Tfap2c is required for placental development and trophoblast stem cell maintenance. Deletion of Tfap2c results in early embryonic loss because of failure in placental development. We evaluated the effect of reduced Tfap2c expression on fetal outcome and placental development. Sixty percent of the heterozygous mice were lost directly after birth. Labyrinthine differentiation was impaired, as indicated by enhanced proliferation and inclusions of cobblestone-shaped cell clusters characterized by expression of Tfap2c and glycogen stores. Moreover, expression of marker genes such as Cdx2, Eomes, Gata3, and Ascl2 are decreased in the spongiotrophoblast and indicate a lowered stem cell potential. On Day 18.5 postcoitum, the labyrinth layer of Tfap2c +/À placentas exhibited massive hemorrhages in the maternal blood spaces; these hemorrhages might have contributed to the significantly reduced number of live-born pups. These morphological alterations were accompanied by a shift toward sinusoidal trophoblast giant cells as the cell subpopulation lining the maternal sinusoids and toward reduction in expression of the prolactin gene family member Prl2c2, a finding characteristic of the spiral arteries lining trophoblast cells. The trophoblast stem cells heterozygous for Tfap2c exhibited a reduction in the expression level of stem cell markers and in their proliferation and differentiation capacity but did not exhibit changes in marker genes of the trophoblast giant cell lineage. Taken together, these findings indicate that a reduction in the gene dosage of placental Tfap2c leads to morphological changes in the labyrinth at midgestation and in the maternal blood spaces during late pregnancy. mouse placenta, sinusoidal trophoblast giant cells, Tfap2c, trophoblast lineage, trophoblast stem cells
INTRODUCTION
Appropriate placental development is crucial for the establishment and maintenance of pregnancy and determines the quality of fetal outcome. The placenta develops from the trophectoderm, which originates from the first lineage decision at the blastocyst stage. Numerous studies using targeted mutation in mice have demonstrated that this first lineage decision, as well as differentiation into the trophoblast subtypes of a functional placenta, is governed by a highly ordered network of transcription factors and signaling pathways [1] . Moreover, the possibility that trophoblast stem cells (TSCs) can be generated from blastocysts or from the extraembryonic ectoderm of wild-type and mutated mice provided more detailed studies of the molecular mechanisms of trophoblast lineage development.
Some of the most important regulators of trophoblast lineage differentiation are members of the family of activating enhancer binding protein 2 transcription factors (Tfap2). Tfap2A-E in mice and TFAP2A-E in humans are involved in balancing proliferation and differentiation in many tissue types [2] . Family members Tfap2a, Tfap2b, and Tfap2c have been shown to be expressed in trophectoderm and in all other extraembryonic derivatives [3, 4] .
During placental development, the expression of Tfap2c is down-regulated in labyrinthine trophoblast cells at approximately Day 11.5 postcoitum (pc) [4] but remains in the spongiotrophoblast and in trophoblast giant cells (TGCs) until term. Tfap2c is expressed not only in parietal TGCs, which are arranged like a shell in the junctional zone, but also by the sinusoidal TGCs (S-TGCs) lining the maternal sinusoids in the labyrinth [4, 5] . It has been demonstrated that the proteins Tfap2A and Tfap2C are maintained in TSC cultures. In addition, Tfap2b is induced when TSCs differentiate along the trophoblast cell lineage [4] . However, studies of mice deficient in Tfap2a or Tfap2-b showed that these genes are not required for placental development, because mutant pups survive in utero but die shortly after birth. Tfap2a mutants exhibit multiple craniofacial defects caused by impaired differentiation of cells of the cranial neural crest cell lineage [6] , whereas mice lacking Tfap2b die of polycystic kidney syndrome [7] .
Deleting the Tfap2c gene, however, results in severe impairment in placental formation, which leads to embryonic death as early as Day 7.5 pc [8, 9] . Proliferation of cells in the trophectoderm of these mutants is reduced and is probably not sufficient to generate the ectoplacental cone and TGCs [8] . These findings demonstrate that embryonic Tfap2c, although expressed in the trophectoderm, is not important for the establishment of the trophectoderm and the following implantation process but is essential for placental formation [4] . In addition to Tfap2c, several other transcription factors, such as Tead4, Cdx2, Eomes, Elf5, Ets2, and Gata3, are detected in the blastocyst stage and are expressed in the extraembryonic ectoderm after implantation. Studies of mutants lacking Tead4 and its target gene Cdx2 demonstrated that these transcription factors act at an even earlier developmental stage, because Tead4 mutants cannot form blastocysts [10] and the blastocysts of Cdx2 mutants fail to implant. Like Cdx2 mutants, mutants homozygous for the eomesodermin gene Eomes, which is a target of Cdx2, die at approximately the time of implantation [11, 12] . As is true of Tfap2c mutants, after deletion of the transcription factors known to be involved in first lineage separation and trophoblast lineage development, other mutant blastocysts are still able to implant but fail in trophoblast lineage development. Blastocysts deficient for Elf5, for example, implant and form an ectoplacental cone but no other extraembryonic derivatives, and TSCs cannot be derived from these blastocysts [13] . Similarly, deletion of Ets2, which encodes a member of the Ets family of nuclear transcription factors [14] , contributes to defects in the maintenance of stem cell potential, which is necessary for developing a placenta from the ectoplacental cone [15] . Gata3 is expressed throughout the trophoblast lineage but at higher levels in the ectoplacental cone than in the extraembryonic ectoderm [16] . Moreover, Gata3 is known to directly regulate Cdx2 transcription and to drive development of the trophoblast cell lineage [16, 17] , but homozygous Gata3 mutant mice did not die before midgestation [18] . This finding suggests that GATA3 exerts important influence on trophoblast lineage development later in placental development. Results of phenotypic analyses of all of these null mouse mutants suggest that there is a highly ordered temporal transcriptional network for placental development with a certain hierarchy of action in the differentiation and specification of the trophectoderm.
Because the loss of Tfap2c leads to a complete loss of placental development [8] , we decided to examine factors that affect lineage development throughout pregnancy. Here we report that reduced levels of Tfap2c throughout pregnancy led to the death of 60% of heterozygous pups shortly after birth. Heterozygous placentas exhibit large hemorrhages at term, and these hemorrhages may contribute to this phenotype. Moreover, the reduction in Tfap2c expression is accompanied by a decrease in expression of lineage marker genes in the spongiotrophoblast and a shift toward S-TGCs. These findings support the hypothesis that Tfap2c exerts cooperative influences on the other regulators of trophoblast lineage differentiation during placental formation.
MATERIALS AND METHODS

Generation of Transgenic Mice and Genotyping
We mated Tfap2c floxtþ mice [8] with CMV-Cre mice (mice were obtained from the animal facility of the University Hospital of Essen, originally described in [19] ) to obtain Tfap2c þ/À mice. These Tfap2c þ/À mice were housed under defined conditions and provided with food and water ad libitum. Tfap2c þ/À males and females were mated overnight, and the day of vaginal plug detection was designated Day 0.5 pc. All experiments were carried out in mice with a mixed 129:C57BL/6j background.
Animal studies were performed in accordance with local and state regulations for research with animals and followed guidelines of Biology of Reproduction for the care and use of experimental animals.
Amniotic sacs were genotyped with a RE-DExtract-N-Amp tissue PCR kit (Sigma-Aldrich, Munich, Germany) according to the manufacturer's protocol. The following primers were used to detect wild-type and null mutant alleles (according to [8] ): P1 (5 0 -AACAGGTTATCATTTGGTTGGGATT-3 0 ), P2 (5 0 -CAATTTTGTCCAACTTCTCCCT CAA-3 0 ), and P3 (5 0 -AATAGTCAGCC ACCGCTTTACTAGG-3 0 ), which amplified 300-bp (wild-type) and 700-bp (null allele) fragments.
Tissue Preparation and Histologic and Morphometric Analyses
Pregnant females were killed at Day 14.5 or 18.5 pc. Embryos and placentas were weighed, and amniotic sacs were collected for genotyping. Depending on the types of experiments to be performed, placentas were either snap frozen in liquid nitrogen or fixed overnight in 4% formalin.
Formalin-fixed tissue for morphologic analysis, in situ hybridization experiments, immunohistochemical analysis, detection of alkaline phosphatase (AP), and periodic acid-Schiff (PAS) staining was routinely embedded, and (7-lm) sections were mounted on Super Frost Plus slides (R. Langenbrinck Laborund Medizintechnik, Emmendingem, Germany). For morphological analysis, sections were stained with hematoxylin and eosin.
For in situ hybridization experiments, sections were deparaffinized and rehydrated through various ethanol gradients and phosphate-buffered saline washing steps. After being treated with proteinase K (20 lg/ml for 15 min at 378C [Qiagen, Hilden, Germany]), sections were postfixed in 4% paraformaldehyde with 0.2% glutaraldehyde, blocked for 2 h, and hybridized with a digoxigenin (DIG)-labeled RNA probe overnight at 658C. On the next day, sections were incubated with anti-DIG antibody, conjugated with AP (1:1000 dilution; Roche, Mannheim, Germany). Nuclear fast red dye (Sigma-Aldrich) was used for counterstaining. After they were dehydrated and incubated in xylene substitute, sections were mounted with xylene substitute mounting medium (Shandon; Thermo Fisher Scientific, Paisley, United Kingdom).
Immunohistochemical analysis was performed routinely with a staining machine (Autostainer 480; Medac, Hamburg, Germany). Briefly, sections were rehydrated and washed, heated, and blocked; they were then incubated with anti-Tfap2c (1:1000 dilution; anti-AP-2c [Tfap2c] antibody [Merck Millipore, Darmstadt, Germany]), anti-Ki67 (1:250 dilution; TEC-3; DAKO, Hamburg, Germany) or anti-CD31 (1:20 dilution; product SZ31; Dianova, Hamburg, Germany) and the appropriate secondary antibody. Hematoxylin was used as a counterstain.
Ki67-positive cells were counted from 3 separate placental areas from 3 serial sections. A total of three placentas from each group (wild-type and heterozygous embryos) were used. Numbers of positive nuclei were quantitated as percentages of total nuclei per area.
For AP staining, samples were deparaffinized, rehydrated, and incubated with Nitro Blue Tetrazolium (NBT)/5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Roche) as a substrate for AP. Nuclear fast red (Sigma-Aldrich) was used for counterstaining.
For detection of glycogen stores in cells of the placenta, a PAS reaction was routinely performed (Autostainer 480; Medac). Briefly, sections were deparaffinized, rehydrated with several ethanol steps, incubated in PAS, washed in tap water, incubated in Schiff reagent, and counterstained with hematoxylin.
For all morphological analyses of differently stained samples, we used 10 serial sections from the middle portion of the placenta. In total, we analyzed 10 placentas from 7 wild-type litters and 14 placentas from 8 heterozygous litters.
Morphometric Analysis
For morphometric analysis, placentas, placental compartments (labyrinth and spongiotrophoblast layer), and placental hemorrhages were measured in serial sections of the central region of least three placentas from mice of each genotype. An Axiophot model microscope (Carl Zeiss, Oberkochen, Germany) with a Nikon DS-U1 camera (Nikon, Germany). NIS-BR 3.1 software (Nikon, Dusseldorf, Germany) was used for determination of areas of the entire placenta and of various layers.
RNA Extraction from Laser-Microdissected Placentas
Laser microdissection and subsequent RNA extraction were performed according to the method described in the bachelor's thesis of Kuehnel [20] . Briefly, we collected placentas from embryos at Day 14.5 pc, immediately froze them in liquid nitrogen, and stored them at À808C. We then cut 10-lm sections with a cryomicrotome (CM model 1850 UV cryostat; Leica, Wetzlar, Germany) and collected the sections on membrane-coated glass slides (Membrane Slides 1.0 PEN [Zeiss]). Samples were fixed with À208C ethanol and stained with cresyl violet (Merck) according to the manufacturer's instructions. To preserve the tissue and improve visualization of the tissue under the microscope, sections were mounted with Liquid Cover Glass (Zeiss). Laser microdissection was performed with the PALM MicroBeam system (Zeiss) with an Axiovert microscope, using PALM RoboSoftware version 4.2 (Zeiss). Samples from the spongiotrophoblast and labyrinth areas were collected separately, and RNA extraction was performed immediately with the RNeasy Micro kit (Qiagen) according to the manufacturer's protocol.
For laser microdissection and subsequent RNA analysis with quantitative real-time polymerase chain reaction (RT-PCR), we examined four placental samples from four wild-type litters and eight placental samples from six heterozygous litters. For cDNA synthesis of whole or microdissected placental samples, we performed quantitative RT-PCR. Reactions were performed in triplicate with 10 ll of SYBR Green Master Mix reagent (Applied Biosystems, Darmstadt, Germany), 1 ll of cDNA stock solution, and 3.75 pmol of specific primers in a total volume of 20 ll. Measurements were performed with the Prism 7300 sequence detector (Applied Biosystems), using corresponding software. For determination of the specificity of the PCR product, we performed a melting curve analysis after amplification. For quantitation, we amplified standardized samples (0.1 fg-1 pg) of cDNA for each of the investigated genes and for the Actb housekeeping gene. The primers used are listed in Table 1 .
Trophoblast Stem Cell Cultures
For cell culture experiments, wild-type and Tfap2c þ/À TSCs were generated from blastocysts at Day 3.5 pc according to the protocol reported by Tanaka et al. [21] . We used blastocysts from 3 wild-type and 3 heterozygous dams for the generation of TSCs. TSCs were cultivated in embryonic fibroblast-conditioned medium (EMFI-CM). We incubated murine EMFIs for 3 days in a TSC medium containing RPMI 1640 medium supplemented with 20% fetal bovine serum (Biochrom, Berlin, Germany), 1 mM sodium pyruvate (Invitrogen), 100 lM b-mercaptoethanol (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen), and 1% penicillin/streptomycin (Invitrogen). EMFI-CM consisted of 75% conditioned TSC medium, 25% unconditioned TSC medium, 25 ng/ml fibroblast growth factor 4 (PeproTech, Hamburg, Germany), and 1 lg/ml heparin (SigmaAldrich). Cells were incubated at 378C under a saturated humidified atmosphere in a NuAire incubator (NuAire, Plymouth, MN) with 20% O 2 and 5% CO 2 .
For proliferation and differentiation experiments, cells were cultured to approximately 75% confluence. For differentiation experiments, 3.5 3 10 5 cells were seeded in each well of a 6-well plate. Analyses were performed in triplicate for both wild-type and heterozygous TSCs. After 24 h under stem cell conditions in EMFI-CM, the medium was changed to TSC medium, and the samples were designated Day 0. Additional samples were collected on Days 1, 2, 3, 5, and 7 of differentiation. RNA was extracted with a Total RNA Kit I (Omega Bio-Tek, Berlin, Germany) according to the manufacturer's instructions. For proliferation experiments, 1.5 3 10 4 cells were seeded in each well of a 24-well plate. Two separate approaches were used to analyze proliferation behavior: one approach used EMFI-CM for undifferentiated growth studies (Day 0), and the other method used TSC medium for differentiation. Cell numbers were determined on Days 1, 3, 5, and 7 of differentiation in TSC medium.
Statistical Analysis
Statistical analyses were performed with Prism version 4.0 software (GraphPad Software, La Jolla, CA). The chi-square test was used to compare the numbers of observed embryos; the Mann-Whitney U test was used for all other comparisons. Statistical significance was set at a P level of ,0.05.
RESULTS
Decreased Survival Rates for Heterozygous Tfap2c Offspring
In previous experiments using mice deficient in Tfap2c, Werling et al. [8] reported a complete absence of Tfap2c À/À pups and a smaller number of heterozygous animals after birth. Homozygous embryos died shortly after implantation because of a deficiency in placental development [8] . To determine the phase of pregnancy at which heterozygous embryos died, we determined the numbers of living heterozygous embryos obtained from heterozygous matings at Day 14.5 pc and reevaluated the number of pups at Postnatal Day 1. To correctly evaluate the results, we modified the Mendelian ratio because of the loss of all homozygous embryos at implantation. At Day 14.5 pc after Tfap2c þ/À 3 Tfap2c þ/À matings, the percentage of heterozygous animals (60.5%) was slightly lower than expected (66.6%), but the number of pups at birth was significantly lower (P 0.001), a finding indicating that approximately 60% of heterozygous embryos are lost in utero between Day 14.5 pc and birth ( Table 2) .
The mean weight of heterozygous embryos was lower than that of wild-type embryos at Day 14.5 pc (0.242 6 0.038 g versus 0.272 6 0.042 g, respectively) and at Day 18.5 pc 
Altered Vessels of Tfap2c þ/À Placentas
To define whether a placental phenotype potentially contributes to the observed embryonic loss, we examined the morphological organization of the Tfap2c þ/À placentas at Days 14.5 and 18.5 pc. On Day 14.5 pc, heterozygous placentas (n ¼ 7) exhibited highly dilated spaces in the spongiotrophoblast layer, whereas wild-type placentas (n ¼ 5) did not (Fig. 1, A-C) , a finding that may indicate altered maternal venous vessels (Fig. 1B) . In the labyrinth layer, neither embryonic vessel density nor maternal lacunas exhibited obvious morphological alterations. On Day 18.5 pc, the spongiotrophoblast layers of heterozygous placentas had recovered and appeared normal, whereas the labyrinthine layers of all examined Tfap2c þ/À placentas exhibited strong alterations with large, randomly distributed hemorrhages (Fig. 1D, arrows) . Those hemorrhages were observed in all heterozygous placentas but varied in extent and size. Morphometric analyses detected hemorrhages of various sizes (from 3.53 mm 2 to 17.74 mm 2 ). On average, these hemorrhages covered approximately 6.61% of the placental area with a maximum coverage of 12.9%. Although the corresponding embryos were alive and exhibited only a tendency toward reduced weight, we hypothesize that these vessel alterations, both the dilated maternal venous vessels in the spongiotrophoblast at Day14.6 pc and the hemorrhages found on Day 18.5 pc, could contribute to the loss of embryos at birth.
To clarify the location and origin of these hemorrhages, we used the marker CD31, which is present only in fetal capillaries and not in maternal sinusoids, which are lined by embryoderived S-TGCs. In the labyrinth, the cells surrounding the maternal hemorrhages were negative for CD31 staining (Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod.org) but positive for AP [22] , a finding demonstrating that the hemorrhages are lined with S-TGCs rather than with true endothelial cells (Fig. 2, A and B) and indicating that the hemorrhages are located in the dilated maternal sinusoids.
Altered Expression of Giant Cell Markers
To clarify whether the impaired vessel formation is related to a shift in trophoblast giant cell lineage differentiation, we used complete placental tissue to evaluate the marker genes relevant to the various subgroups. S-TGCs predominantly express the cathepsin Q (Ctsq) and prolactin Prl3b1 genes, whereas TGCs lining the canal (C-TGCs) express both the Prl3b1 and the Prl2c2 genes. TGCs that line the maternal spiral arteries (SpA-TGCs) express only Prl2c2, whereas parietal TGCs (P-TGCs) express a combination of Prl3d1, Prl3b1, and Prl2c2 [23] . Interestingly, we found that Ctsq expression was significantly higher in Tfap2c þ/À placentas than in wild-type placentas (Fig. 3A) , whereas the expression of the prolactin family members Prl3d1 (Fig. 3B) , Prl3b1 (Fig. 3C) , and Prl2c2 (Fig. 3D) was down-regulated. These changes in the expression levels of TGC markers point to a shift in giant cell differentiation toward morphologically altered S-TGCs.
Effects on Labyrinth Differentiation
Reduction in Tfap2c levels resulted in a significantly higher proliferation rate of labyrinthine trophoblasts than in wild-type placentas, as demonstrated by Ki67 staining at 14.5 days pc (Fig. 4, A-C) . Moreover, on Day 14.5 pc, the placentas exhibited clusters of densely packed cuboidal cells within the labyrinth layer. (Fig. 5A, dotted lines) . These clusters were characterized by staining for Tfap2C and Ki67 (Fig. 5, C and  D) . To further characterize these cells, we performed in situ hybridization analysis for Tpbpa and PAS staining. Nearly all clusters stained positive for Tpbpa expression and PAS staining for glycogen stores, a finding indicating a differentiation into the spongiotrophoblast lineage (Fig.5, E and F) . Some of these clusters, which were similar in appearance to undifferentiated trophoblast cells or spongiotrophoblast cells, were still present on Day 18.5 pc (Supplemental Fig. S2 , A-E)
Altered Expression of Labyrinthine and Spongiotrophoblast Marker Genes
To identify compartment-specific differences in the expression of regulatory genes in trophoblast differentiation, we performed separate laser microdissection studies to investigate the mRNA expression profiles of the labyrinth and spongiotrophoblast layers of Tfap2c heterozygous mice at Day 14.5 pc. As expected heterozygous animals exhibited lower levels of Tfap2c transcripts in the spongiotrophoblast layer at Day 14.5 pc than did controls (Fig. 6) . The labyrinth layer of heterozygous and wild-type mice exhibited similar numbers of Tfap2c transcripts; these similarities could be caused by the clusters of Tfap2c-positive cells in the labyrinth layer of heterozygous placentas (Fig. 6A ). Although we found several clusters of trophoblast cells resembling spongiotrophoblast cells within the labyrinth, Gcm1 expression, crucial for labyrinthine trophoblast formation, was not altered (data not shown). Like Tfap2c, the trophoblast stem cell marker Cdx2 tends to be down-regulated in the spongiotrophoblast layer (Fig. 6B) . The reduced gene dosage of Tfap2c is a further indication of the relationship between the expression of Tfap2c and the reduced expression of Cdx2 [4] . The expression level of Gata3, which regulates trophoblast development downstream in parallel with Cdx2 [16] , was also significantly lower in the spongiotrophoblast layer of heterozygous placentas than in wild-type placentas (Fig. 6D) . These three factors, Cdx2, Tfap2c, and Gata3, form a positive feedback loop that balances maintenance of the progenitor state and promotion of trophoblast lineage differentiation. The relative expression of Tead4, the upstream regulator of Cdx2 and Gata3, however, was not altered (Fig. 6E) . Only a slight reduction was seen in the expression levels of Cited2, a factor that plays a role in placental vascularization [24] . The expression of Ascl2, which is important for initiating the differentiation of trophoblast cells into their various subpopulations, was significantly reduced in Tfap2c heterozygous mice (Fig. 6F) .
To gain more insight into these changes in proliferation and differentiation behaviors, we examined the expression level of the maternally imprinted cyclin-dependent kinase inhibitor Cdkn1c (formerly p57 Kip2 ), which regulates the cell cycle and promotes differentiation [25] , in the various compartments (Fig. 6G) . Expression of Cdkn1c tended to be up-regulated in both layers of heterozygous placentas, a finding pointing toward a higher likelihood of arrest in the G 1 cell cycle phase.
Expression of the marker genes for the function and development of glycogen cells was not altered. Expression of Igf2, a paternally expressed growth factor that normally promotes placental growth and transport capability and, therefore, fetal growth [26, 27] , was not significantly different between Tfap2c þ/þ and Tfap2c þ/À samples. The pleckstrin homology-like domain family A, member 2 gene (Phlda2), a maternally imprinted gene, is expressed primarily in the labyrinth layer [28] and is supposed to coordinate the location of spongiotrophoblast cells and glycogen cells in late gestation [29] . Expression levels of the Phlda2 transcript were slightly higher in both the labyrinth and the spongiotrophoblast layers REDUCED Tfap2c EXPRESSION ALTERS MOUSE PLACENTA in placentas of heterozygous animals than in wild-type animals at Day 14.5 pc (Fig. 7C) . This observation could be the consequence of significant down-regulation of Ascl2 in the spongiotrophoblast layer of Tfap2c þ/À placentas (Fig. 6F) .
However, using morphometric analyses, we found no changes in the size or location of glycogen cell clusters in heterozygous placentas (data not shown). Thus, the slight down-regulation of Phlda2 had no obvious effect on glycogen cell differentiation 
Effects of Tfap2c þ/À on Trophoblast Stem Cell Differentiation
To further analyze the effect of a reduction in Tfap2c gene dosage on trophoblast lineage development, we generated TSCs from Tfap2c þ/À blastocysts. We cultivated Tfap2c
TSCs for 7 days with EMFI-CM to maintain the stem cell state (Fig. 8A) or without EMFI-CM to induce differentiation (Fig.  8B) . Under both conditions, proliferation of Tfap2c þ/À TSCs was significantly slower and even more pronounced during differentiation than in wild-type TSCs (Fig. 8, A and B) .
This strong reduction in proliferation could be related to the loss of stem cell potential when Tfap2c levels are reduced. To test this hypothesis, we differentiated TSCs for 7 days after the withdrawal of EMFI-CM and recorded the expression patterns of the markers relevant for TSC maintenance during this period. First, we confirmed that the expression level of Tfap2c was lower in heterozygous samples than in wild-type samples from Day 0 to Day 3 of differentiation; this difference was statistically significant on Days 2 (P 0.05) and 3 (P 0.01). At Days 5 and 7, we observed similar levels of the transcript in wild-type and mutant TSCs (Fig. 9A) . Thus, the up-regulation of Tfap2c, which is normally found during wild-type TSC differentiation [3] , was absent in the mutants. The levels of both Cdx2 (Fig. 9C) and Eomes (Fig. 9D) , both of which are key players in maintaining the stem cell state and whose expression is normally high in the undifferentiated state at Day 0 and decreases rapidly during early differentiation of TSCs, were significantly lower in undifferentiated Tfap2c þ/À TSCs than in wild-type TSCs. The levels of Gata3 were lower than wild-type levels during differentiation but never significantly lower (Fig. 9B) . This finding suggests a reduction of the stem cell characteristics of mutant TSCs with reduced Tfap2c levels and could explain the reduced proliferation capability of these TSCs. Ascl2 expression levels, which are known to be normally strongly up-regulated on Day 2 of differentiation before they rapidly decrease during differentiation [30] , remained low in Tfap2c þ/À TSCs but were consistently higher than those in control cells on Days 5 to 7 of differentiation (Fig.  9E) . Despite the fact that the expression of stem cell markers was strongly reduced in undifferentiated Tfap2c þ/À TSCs, the expression levels of the giant cell marker Cdkn1c were unaffected in Tfap2c þ/À cells (data not shown). Because it has been well documented that the gap junction protein connexin 31 (Cx31) is a marker for stem cells in TSCs [30] and because it has been shown that TSCs deficient in Gjb3 exhibit a lower expression level of Tfap2c in the differentiated REDUCED Tfap2c EXPRESSION ALTERS MOUSE PLACENTA state [31] , we investigated the expression profile of Gjb3. Interestingly, during differentiation Gjb3 followed the expression profile of both the wild-type and the Tfap2c þ/À TSCs. Like Tfap2c expression, Gjb3 expression was not up-regulated during Days 0 to 3 in heterozygous mutant TSCs and exhibited adjusted levels in wild-type TSCs on Days 5 and 7 (Fig. 9F) .
Surprisingly, we found no significant differences among expression levels of the marker genes Prl3d1, Prl3b1, Prl2c2, and Ctsq between Tfap2c þ/À TSCs and wild-type TSCs, and the variations between the clones in respect to marker genes were high (Supplemental Fig. S3 ).
DISCUSSION
In the present study, we found that reduced Tfap2c expression levels in the placentas of Tfap2c þ/À mice resulted in the loss of 60% of heterozygous pups starting from Day 14.5 pc onward, probably because of altered maternal sinusoid formation with hemorrhages in the later stages of pregnancy. This phenotype also exhibited altered differentiation of trophoblast subpopulations, as indicated by the expression of compartment-specific marker genes for lineage development, such as Cdx2, Eomes, Gata3, and Ascl2. Moreover, markers of the TGC lineage were altered in favor of the trophoblast cells lining the maternal sinusoids. Thus, Tfap2c is important not only for stem cell maintenance at the beginning of placental formation after implantation, as shown in knockout mice [8, 9] , but also for further differentiation into a functional placenta. The results obtained from studies of TSCs heterozygous for Tfap2c corroborated the finding that reduced levels of Tfap2c lead not only to a reduction in stem cell potential before differentiation but also to an alteration in the regulation of marker genes, such as Gata3, Cdx2, Eomes, and Ascl2, during trophoblast lineage differentiation.
Morphological Alterations of the Placenta
Although the weights of the embryos and placentas were slightly lower in mice heterozygous for Tfap2c than in wildtype mice on Days 14.5 and 18.5 pc, permanent malnutrition does not seem to be a likely cause of the observed embryonic loss. This reduced weight could be related to altered differentiation of the labyrinth layer, which was indicated by our observations of prolonged proliferation and inclusions of trophoblast cell clusters resembling more spongiotrophoblast cells. The death of Tfapc2 þ/À embryos, which seems to occur during the second period of pregnancy, could be related to the impairment of the maternal vessel system, leading to large hemorrhages and a complete and sudden stop in the fetomaternal exchange. Although we cannot completely exclude the possibility that the embryos die shortly after birth and are cannibalized by the mothers, we emphasize the point that the surviving heterozygous pups are overtly normal in life span, growth, and behavior.
A similar phenotype exhibiting large lacunas in the spongiotrophoblast layer at Day 14.5 pc and hemorrhages in the labyrinth at Day 18.5 pc has been observed in SynB À/À mice [32] . In addition, these mice exhibit impaired formation of syncytiotrophoblast layer II and destroyed integrity of maternal vessels. Researchers have assumed that a thinning of vessel walls in combination with an increase in maternal blood pressure may cause reductions in the number of pups. A similar mechanism can account for the phenotype observed in our study: Defects in maternal vessels could lead to the enlargement of sinusoidal vessels in the spongiotrophoblast and to rupture in some labyrinthine blood spaces of the placentas during late gestation, and these problems may cause severe bleeding and the late death of 60% of heterozygous embryos. This phenomenon seems to occur in association with changes in TGC differentiation, as discussed below. þ/À placentas, whereas down-regulation of Gata3 (D) in these placentas was statistically significant (*P 0.05). Expression of the marker gene Tead4 (E) was not altered in the heterozygous samples. Expression of Ascl (F) was significantly down-regulated in samples from spongiotrophoblast layer Tfap2c þ/À placentas, whereas expression of Cdkn1c (G) tended toward higher expression in both layers. Lab ¼ labyrinth; Spongio ¼ spongiotrophoblast.
REDUCED Tfap2c EXPRESSION ALTERS MOUSE PLACENTA
Disturbed Differentiation of Giant Cell Subtypes as a Possible Cause of Vessel Malfunction
Both the AP staining and the increase in expression of the giant cell marker Ctsq point to problems with S-TGC differentiation in placentas heterozygous for Tfap2c, combined with morphologically altered maternal sinusoids. In contrast to Ctsq, expression of the markers of the other subtypes was reduced, predominantly Prl2c2, the marker of the SpA-TGCs lining the maternal spiral arteries [23] . Why the expression of the second marker for S-TGC, Prl3d1, was reduced instead of enhanced requires further clarification. Because Prl3d1 is also expressed by P-TGCs and C-TGCs, this phenomenon could be explained by an extremely strong reduction in expression of this marker in these subpopulations of TGCs or by a loss of Prl3d1 by S-TGCs. The significant shift toward S-TGCs may lead to changes in maternal sinusoid formation, resulting in slow blood flow into the placenta, which in turn causes the hemorrhages.
Alterations in Expression of Compartment-Specific Lineage Marker Genes
Tfap2c
þ/À placentas exhibited obvious alterations in expression of marker genes. Because the spongiotrophoblast layer originates from the ectoplacental cone, where Tfap2c is permanently expressed [8] , most of the changes in trophoblast lineage marker genes were found in this layer. Reduction in the number of Gata3 and Cdx2 transcripts, both of which are regulators of trophoblast development, points to a delay in differentiation in the spongiotrophoblast layer and confirms the influence of the combination of Gata3 and Tfap2c on trophoblast lineage development during later stages of placental development. A smaller amount of Ascl2 transcripts were seen in the spongiotrophoblast layer, but unlike the Ascl2 À/À phenotype, which is characterized by the emergence of almost no spongiotrophoblast cells [33] , the overall appearance of Tfap2c þ/À placentas exhibited only a slight disturbance in the formation of the spongiotrophoblast layer. It is known that a loss of Ascl2 function elevates expression of the imprinted gene Phlda2 [34] . The hypomorphic Ascl2 allele, which results in higher Phlda2 expression levels, causes embryonic growth restriction and an associated placental phenotype characterized by reductions in placental weight and spongiotrophoblast populations, the absence of glycogen cells, and an expanded TGC layer. The labyrinth layer of maternal mutants also exhibited severe defects, including increased production of the trilaminar labyrinth trophoblast cell types and a disorganized labyrinthine vasculature [34] . Elevated levels of PHLDA2 expression are also negatively correlated with low birth weight in humans [35] . In our study, the slightly elevated gene dosage of Phlda2 observed at Day 14.5 pc was not associated with alterations in glycogen cells or Igf2 levels and thus could not explain the reduced weight of the embryos at Day 14.5 pc, as described by Tunster et al. [29] .
Cited2 is another interesting marker gene for lineage differentiation; its expression is reduced in the spongiotrophoblast layer of heterozygous Tcfap2 mice. In the published model of Cited2-deficient mice [24] , the numbers of giant cells, FIG. 7 . Expression of genes characteristic of glycogen cells. Samples of laser-microdissected placentas were collected on Day 14.5 pc. There were no differences between Igf2 expression in wild-type and those in heterozygous samples (A). Expression levels of Phlda2 (B) in the heterozygous samples tended to be higher in the spongiotrophoblast and labyrinth layers. Lab ¼ labyrinth; Spongio ¼ spongiotrophoblast.
FIG. 8. Reduced proliferation in Tfap2c
þ/À TSCs. Heterozygous TSCs exhibited a significantly lower proliferation capability than did wild-type stem cells, both with EMFI-CM for stem cell conditions (A) and without EMFI-CM for the induction of differentiation (B). **P 0.01; ***P 0.001. spongiotrophoblast cells, and glycogen cells were reduced, and problems occurred in the proper formation of the embryonic vessels because of a lower proliferation rate in the ectoplacental cone. However, the described placental phenotype is not comparable to the one described here.
The results of studies of the proliferation properties of placenta with reduced Tfap2c levels were unexpected. The placentas heterozygous for Tfap2c still showed proliferative activity at Day 14.5 pc; this finding points toward delayed placental development. Furthermore, the labyrinth layer contains patches of trophoblast cells not differentiated into labyrinthine trophoblast. Interestingly, deletion of the retinoblastoma (Rb) gene led to a similar but more severe phenotype, with strongly enhanced proliferation on Day 13.5 pc and dysplasia of the labyrinth with small clusters of TSC cells heavily labeled with bromodeoxyuridine and Eomes [36] .
Tfap2c is known to maintain stem cell potential, and a reduction in gene dosage should result in a loss of stem cell potential and proliferation capacity. This unexpected result could be explained by two facts: first, Tfap2c seems to play a crucial role in the induction of placental formation by proliferation; and second, in combination with other transcription factors such as Ascl2 and Gata3 and Tfap2c seems to be responsible for enforcing lineage differentiation. Interestingly, in normal placentas Tfap2c remains in the labyrinth only until Day 11.5 pc [5] , and an appropriate dosage of Tfap2c seems to be necessary for the initiation of differentiation into a functional placenta. This assumption is supported by the findings of the in vitro investigations described below.
Moreover, expression of Cdkn1c, a member of the Cip/Kip p57 family, is enhanced predominantly in the labyrinth layer of heterozygous Tfap2c placentas. Deletion of this CDK inhibitor FIG. 9 . Expression patterns of trophoblast cell lineage marker genes in TSCs. After 7 days of differentiation, TSCs were investigated for expression profiles of trophoblast lineage marker genes. In Tfap2c þ/À cells, the expression levels of Tfap2c (A) and Gata3 (B) started at lower levels than those in wild-type TSC, and there was a delay in up-regulation during differentiation. Expression levels of the stem cell markers Cdx2 (C) and Eomes (D) were strongly reduced on Day 0, with no regulation. At Day 2 of differentiation, Ascl2 expression (E) was not higher in Tfap2c þ/À cells than in wild-type TSCs. Gjb3 (Cx31) was expressed in a regulation pattern similar to that of Tfap2c and exhibited lower expression (F). *P 0.05; **P 0.01; ***P 0.001. REDUCED Tfap2c EXPRESSION ALTERS MOUSE PLACENTA has been associated with high trophoblastic proliferation [37] and labyrinthine hyperplasia, a phenotype similar to that of our Tfap2c þ/À and to that of Rb knockout mice [36] . The higher levels of Cdknc1 expression could be a mechanism that compensates for the enhanced proliferation properties. Thus, the regulation between maintaining stem cell capacity at the beginning of placental formation and induction of trophoblast lineage differentiation seems to be more complicated than previously appreciated.
TSCs Heterozygous for Tfap2c Exhibited Reduced Proliferation
We could generate Tfap2c þ/À TSCs but only with an extremely low proliferation capability in combination with highly reduced levels of stem cell markers such as Cdx2, Eomes, and Gata3 in the undifferentiated state of the TSCs, a finding indicating that their stem cell characteristics are nearly lost.
During differentiation, TSCs did not respond in an appropriate manner. Neither an adequate temporal up-regulation of Ascl2, Tfap2c, or Gata3 nor a down-regulation of Cdx2 was present. This non-responsiveness of the marker genes, predominantly the missing up-regulation of Ascl2, to differentiation stimuli could explain the in vivo maintenance of undifferentiated patches of cells in the differentiated placental labyrinth.
Notably, within this network of stem cell markers, the gap junction gene Gjb3 follows the same expression pattern as that of the transcription factor Tfap2c, a result that confirms our previous finding [31] that the expression profiles of both markers are directly correlated. In Gjb3 À/À TSCs, the loss of Gjb3 influences the regulation of Tfap2c in vitro by blocking its up-regulation during the differentiation process. In the current study we showed a relationship between Tfap2c and Gjb3: a reduction in the expression of Tfap2c reduces expression of Gjb3.
Gjb3 is a marker gene of the extraembryonic ectoderm lineage and is maintained in the spongiotrophoblast layer throughout pregnancy [38] . Interestingly, as is true of the reduction in Tfap2c expression levels, a deficiency of Gjb3 in TS cells results in a strongly reduced proliferation capability and in a reduction in the levels of stem cell markers [30] . Moreover, the loss of CX31 alters the giant cell differentiation pathway with a shift from P-TGCs to S-TGCs and C-TGCs [29] , whereas a reduction in Tfap2c levels seems to enhance only the development into S-TGCs. It seems that Gjb3 and Tfap2c are not only regulated in the same way but also share physiological properties of stem cell and trophoblast lineage development.
Results of our experiments with Tfap2c þ/À TSCs are only partially in line with in vivo results. Results obtained from our studies of TSC cultures support the hypothesis that the TSC model plays the role of Tfap2c in the time frame of very early trophoblast lineage development and also for spongiotrophoblast differentiation but not for differentiation into the giant cell pathway. This difference could be explained by the fact that differentiation into the appropriate sublineages of giant cells is not only endogenously controlled but also influenced by the maternal environment and the three-dimensional arrangement of placental tissue.
Results of our study indicate that the reduction in Tfap2c levels in heterozygous mice is related to changes in the expression of marker genes predominantly in the spongiotrophoblast layer and that Tfap2c is integrated into the cascade of transcription factors that are responsible not only for stem cell maintenance but also for trophoblast lineage differentiation. The altered balance in giant cell subpopulations toward STGCs is probably the cause of alterations in the formation of maternal vessels and blood spaces and of hemorrhages. These defects in blood vessel formation seem to be the most likely cause of the loss of heterozygote embryos between Day 14.5 pc and birth.
